Merck Stock News

GENEVA: US pharmaceutical giant Pfizer on Tuesday (Wednesday in Manila) announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world''s least-wealthy countries. Pfizer will sublicense production of its promising Paxlovid pill to generic drug manufacturers for supply in 95 low- and middle-income nations covering around 53 percent (around 3.8 billion) of the world''s population. Under the deal struck with the global Medicines Patent Pool (MPP), Pfizer which also produces one of the most widely used Covid vaccines with German lab BioNTech will not receive royalties from the generic manufacturers, making the treatment cheaper. The agreement is subject to the oral antiviral medication passing ongoing trials and regulatory approval. The Pfizer drug is to be taken with the human immunodeficiency virus medicine ritonavir. Interim data from ongoing trials demonstrated an 89-percent reduction in the risk of Covid-19-related hospitalization or death compared to a placebo, in nonhospitalized high-risk adults with Covid-19 within three days of symptom onset, said Pfizer.

Related Stocks: MRK , CSCO , IBM , BRK.B , UL , CNP , TFC , LMT , CMC , CNO , XEC , WRK , BA , QELL , SPNV , MKTW , RAAC , STPC ,

CAMBRIDGE, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the appointment of Stephen L. Mayo, Ph.D., to its Board of Directors, effective immediately. Dr. Mayo is currently the Bren Professor of Biology and Chemistry at California Institute of Technology (Caltech), and serves on the board of directors for Merck and on the scientific advisory board of Rubryc Therapeutics.

This Poultry Health market research stud offers proper industry viewpoint, market size, growth, future trends and trading. All this are taken into consideration while preparing the market report with the forecast period from 2021 to 2027. This report contains a

Market trends, major suppliers and competitive landscape are covered in this Periodic Fever Syndrome market study along with capturing market scenario estimation for the foretell duration 2021-2027. By adopting a few key business indicators, key players aim at expanding their

Related Stocks: EW , ISEE , BLU , EGRX , CYCC , BAX , SGEN , MRK , SKIN , SRPT , LEGN , JAZZ , PTGX , JNJ , CI , ALDX , PFE ,

Rotavirus vaccine is applied to prevent against rotavirus infections which can cause severe diarrhoea amongst young children. Symptoms of rotavirus infection consist of severe diarrhoea, vomiting, fever, and abdominal pain which can cause the disease. Rotavirus vaccine is given by

Dr. Reddy''s Laboratories Ltd (NYSE: RDY ) said it was open to making Pfizer Inc''s (NYSE: PFE ) COVID-19 antiviral pill, Reuters reported . The new drugs can be used to treat patients once they contract coronavirus infection and are expected to be a substantial market. Merck Inc (NYSE: MRK ) has given out licenses to manufacturers in developing countries to ensure a swift global supply, and Full story available on Benzinga.com

Charles Gore, head of the Medicines Patent Pool, said a deal to expand access to Pfizer''s Covid-19 pill "may play a crucial role in saving lives and helping to fight

CAMBRIDGE, Mass. and SUZHOU, Jiangsu, China , Nov. 16, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement-targeted therapies to treat immune-mediated diseases, today announced the appointment of Teri Loxam as Chief Operating Officer (COO) and Chief Financial Officer (CFO). Ms. Loxam will replace interim CFO Matt Gorman and will oversee finance along with several strategic and operational functions of the company. "We are delighted to welcome Teri to the Kira executive team. As Kira continues to build momentum and advance through the clinic, Teri''s wealth of experience across finance, strategy, investor relations and communications will be invaluable" said Frederick Beddingfield , MD, PhD, CEO of Kira Pharmaceuticals. "We will benefit from her strong relationships across the life sciences and investment communities and her strength in operational execution and building teams as we continue to grow and bring much needed therapies to patients." Ms.

no deaths recorded, 55 new cases detected Health Minister, Dr Frank Anthony said Government is examining whether it will be procuring any of the two anti-viral COVID-19 pills which have been recently developed. Paxlovid, developed by Pfizer, and Molnupiravir, by Merck and Ridgeback Biotherapeutics, have proven to significantly reduce both hospitalisations and deaths. Were [] The post Govt mulls procuring COVID-19 pills appeared first on Guyana Times .

Various crucial findings depicted in this Musculoskeletal Medicine market report are the result of primary and secondary research carried out by the analysts. In order to provide the relevant data, analysts and financial experts take great efforts to bring efficient

During this Gastro Esophageal Reflux Disease (GERD) Drug market report, a precise and accurate analysis of growing market is presented and obtainable. It contains a detailed market overview, such as snapshots and statistics, which provide detailed information on numerous segmentations.

Anti-venom Market 2021 The global Anti-venom Market research report provides an in-depth analysis of the industry''s current and future situation. The study, which was completed utilizing extensive primary and secondary research, has all of the necessary market data. The report includes